- Home
- JCSE vs MBIO Comparison
JCSE vs MBIO Comparison
Compare JCSE & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- MBIO
- Stock Information
- Founded
- JCSE 1999
- MBIO 2015
- Country
- JCSE Singapore
- MBIO United States
- Employees
- JCSE N/A
- MBIO 80
- Industry
- JCSE Miscellaneous manufacturing industries
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- MBIO Health Care
- Exchange
- JCSE Nasdaq
- MBIO Nasdaq
- Market Cap
- JCSE 7.6M
- MBIO 7.3M
- IPO Year
- JCSE 2022
- MBIO N/A
- Fundamental
- Price
- JCSE $1.47
- MBIO $5.55
- Analyst Decision
- JCSE
- MBIO Strong Buy
- Analyst Count
- JCSE 0
- MBIO 1
- Target Price
- JCSE N/A
- MBIO $2.00
- AVG Volume (30 Days)
- JCSE 35.1K
- MBIO 468.6K
- Earning Date
- JCSE 10-30-2024
- MBIO 03-10-2025
- Dividend Yield
- JCSE 12.29%
- MBIO N/A
- EPS Growth
- JCSE N/A
- MBIO N/A
- EPS
- JCSE 0.12
- MBIO N/A
- Revenue
- JCSE $14,723,999.00
- MBIO N/A
- Revenue This Year
- JCSE N/A
- MBIO N/A
- Revenue Next Year
- JCSE N/A
- MBIO N/A
- P/E Ratio
- JCSE $11.87
- MBIO N/A
- Revenue Growth
- JCSE N/A
- MBIO N/A
- 52 Week Low
- JCSE $0.60
- MBIO $5.19
- 52 Week High
- JCSE $2.39
- MBIO $76.00
- Technical
- Relative Strength Index (RSI)
- JCSE 51.62
- MBIO 31.43
- Support Level
- JCSE $1.37
- MBIO $5.19
- Resistance Level
- JCSE $1.48
- MBIO $13.30
- Average True Range (ATR)
- JCSE 0.11
- MBIO 2.31
- MACD
- JCSE -0.00
- MBIO -0.47
- Stochastic Oscillator
- JCSE 47.14
- MBIO 2.14
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.